Paediatric overdiagnosis modelled by coronary abnormality trends in Kawasaki disease

Eric R Coon1, Jacob Wilkes2, Susan L Bratton3

  • 1Department of Pediatrics, Division of Hospital Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Insights

Diagnoses of non-severe coronary artery abnormalities in children with Kawasaki disease (KD) increased significantly, while severe abnormalities and adverse cardiac outcomes remained stable. This pattern suggests potential overdiagnosis of coronary artery issues in pediatric KD patients.

Area of Science:

  • Pediatric Cardiology
  • Kawasaki Disease Research
  • Diagnostic Trends

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Coronary artery abnormalities (CAAs) are a significant complication of KD.
  • Overdiagnosis of CAAs in KD has been a concern.

Purpose of the Study:

  • To compare trends in CAA diagnoses with adverse cardiac outcomes in children with KD.
  • To evaluate if increasing CAA detection fits an overdiagnosis model.

Main Methods:

  • Retrospective cohort study of 17,809 children diagnosed with KD between 2000-2014 across 48 US hospitals.
  • Analyzed rates of coronary artery abnormality diagnoses (severe and non-severe) and adverse cardiac outcomes.
  • Used mixed effects logistic regression to assess trends over time, adjusting for demographics.

Main Results:

  • The rate of non-severe CAA diagnoses increased from 4.5% in 2000 to 8.1% in 2014 (adjusted 2.3-fold increased odds).
  • Diagnoses of severe CAAs remained stable.
  • Adverse cardiac outcomes showed no significant trend over the study period (1.9% prevalence).

Conclusions:

  • The rising incidence of non-severe CAA diagnoses, without a corresponding increase in adverse cardiac outcomes, is consistent with an overdiagnosis pattern in pediatric KD.
  • This suggests a need to re-evaluate diagnostic criteria or practices for CAAs in children with KD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K